Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03059485
Title DC/AML Fusion Cell Vaccine vs DC/AML Fusion Cell Vaccine Plus Durvalumab vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute myeloid leukemia

Therapies

DC AML Vaccine

DC AML Vaccine + Durvalumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory Winship Cancer Institute Recruiting Atlanta Georgia 30033 United States Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02214 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
University of Wisconsin Carbone Cancer Center Recruiting Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field